Clinical effect of vitamin D3 analogues is not inactivated by subsequent UV exposure

Photodermatology Photoimmunology and Photomedicine

Volumn 24, Issue 1, 2008, Pages 16-18

  Adachi, Yuka ^a   Uchida, Naoko ^a   Matsuo, Tomoo ^a   Horio, Takeshi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Calcipotriol; Maxacalcitol; Phototherapy; Psoriasis; Vitamin D3 analogue

Indexed keywords

22 OXACALCITRIOL; CALCIPOTRIOL; COLECALCIFEROL DERIVATIVE; CORTICOSTEROID; METHOXSALEN; PETROLATUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; NARROW BAND ULTRAVIOLET B RADIATION; OUTCOME ASSESSMENT; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA; RANDOMIZED CONTROLLED TRIAL; ULTRAVIOLET B RADIATION;

ADMINISTRATION, CUTANEOUS; ADULT; CALCITRIOL; CHOLECALCIFEROL; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSORIASIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 38349032590     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2008.00327.x     Document Type: Article

References (13)

1. Kragballe K, Beck HI, Sogaard H. Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double blind study. Br J Dermatol 1988; 119: 223-230.
2. Kragballe K. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903). Arch Dermatol 1989; 124: 1647-1652.
3. Dubertret L, Wallach D, Souteyrand P, et al. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. J Am Acad Dermatol 1992; 27: 983-988.
4. Highton A, Quell J. Calcipotrien ointment 0.005% for psoriasis: A safety and efficacy study. J Am Acad Dermatol 1995; 32: 67-72.
5. Kragballe K. Combinaton of topical calcipotriol (MC 903) and UVB radiation for psoriasis vulgaris. Dermatologica 1990; 181: 211-214.
6. Kerscher M, Volkenlamdt M, Plewig G, Lehmann P. Combination phototherapy of psoriasis with cacipotriol and narrow-band UVB. Lancet 1993; 342: 923.
7. Kokelj F, Lavaroni G, Guadagnini A. UVB versus UVB plus calcipotriol (MC 903) therapy for psoriasis vulgaris. Acta Derm Venerol (Stockholm) 1995; 75: 386-387.
8. Speight EL, Farr PM. Calcipotriol improves the response of psoriasis to PUVA. Br J Dermatol 1994; 130: 79-82.
9. Farr PM, Diffey BL, Steele MC. A preliminary study on the in vivo transmission of light through psoriatic plaques. Photodermatology 1984; 1: 87-90.
10. Lebwohl M, Martinez J, Weber P, DeLuca R. Effects of topical preparations on the erythemogenicity of UVB: Implications for psoriasis phototherapy. J Am Acad Dermatol 1995; 32: 469-471.
11. Lebwohl M, Quijije J, Gilliard J, Rollin T, Watts O. Topical calcitriol is degraded by ultraviolet light. J Invest Dermatol 2003; 121: 594-595.
12. Marsico RE, Dijkstra JWE. UVB blocking effect of calcipotriene ointment 0.005%. J Am Acad Dermatol 1996; 34: 539-540.
13. De Rie MA, Di Nuzzo S, Brands S, Hansen AB, Bos JD. Calcipotriol ointment and cream or their vehicles applied immediately before irradiation inhibit ultraviolet B-induced erythema. Br J Dermatol 2000; 142: 1160-1165.